IP Library Granted Patent US 9,283,253
Granted Patent B2
US 9,283,253 · App. 13/932,520 · Granted Mar 15, 2016

Metallo-lactoferrin-coenzyme compositions for detoxification support

Inventors: A. Satyanarayan Naidu (Anaheim Hills, CA); A.G. Tezus Naidu (Anaheim Hills, CA); A.G. Sreus Naidu (Anaheim Hills, CA)
Assignee: NAIDU LP
A61K35/745A23L1/034A23L1/293A23L1/3002A23L1/302A23L1/304A23L1/305A23L1/3006A23L1/308A23L1/3014A23L1/3051A23L1/3056A61K9/0095A61K9/1617A61K31/715A61K31/718A61K31/737A61K35/747A61K36/185A61K36/27A61K36/48A61K36/54A61K36/55A61K36/68A61K38/40A61K38/44A61K38/446A61K38/47A61K45/06A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,283,253
App. No.
13/932,520
Granted
Mar 15, 2016
Kind
B2
Abstract

Formulations are provided for detoxification support. The formulations generally include a trigger complex, an elemental complex and a coenzyme-vitamin B complex. The trigger complex is high in fiber such as glucomannan and includes Metallo-Lactoferrin protein in an alkaline buffer system. The elemental complex includes one or more trace element as a suitable salt. The coenzyme-vitamin B complex includes one or more coenzyme, coenzyme precursor and/or B-vitamin. The compositions may optionally include additional components such as Lactic Acid bacteria, L-theanine, cranberry root extract, tumeric root extract, inulin and blond psyllium. The compositions can be administered orally in a variety of forms.

Claims (27)

1. A composition for detoxification support comprising:

a trigger complex comprising a lactoferrin (LF) comprising a zinc ion covalently bound to the LF and at least one hydrocolloid compound at alkaline pH,

an elemental complex comprising a zinc metal salt,

a coenzyme complex comprising at least one coenzyme or coenzyme precursor, and

a probiotic Lactic acid bacteria, wherein the concentration of LF in the composition is from 0.2 to 5% (wt/wt).

2. The composition of claim 1 , wherein the lactoferrin is lactoferrin-treated for contaminant reduction (LF-TCR).

3. The composition of claim 1 , wherein the hydrocolloid compound is selected from the group consisting of edible celluloses, arabinogalactan, β-glucans, arabinoxylans, glucuronoxylans, xyloglucans, galactomannans, methyl cellulose, hydroxypropylmethyl cellulose (HPMC), inulin, oligofructans, xanthan gum, guar gum, locust bean gum, gum acacia, gum karaya, gum tragacanth, resistant starches, maltodextrins, chemically synthesized polydextrose, lactulose, cellulose derivatives, methyl cellulose, hydroxypropylmethylcellulose, egg lecithin, soybean lecithin, vegilecithin, vitellin, short chain fructooligosaccharides (FOS), transgalactooligosaccharides (TOS), levan, oligofructose, xylooligosaccharides (XOS), curdlan, chitin, chitosan, collagen and chondroitin.

4. The composition of claim 1 , wherein the alkaline pH is provided by a carbonate/bicarbonate buffer system.

5. The composition of claim 1 , wherein the hydrocolloid is selected from the group consisting of maltodextrins, chitin, chitosan, cellulose derivatives, glucomannan, guar gum, locust bean gum, prickly pear cactus and combinations thereof.

6. The composition of claim 1 , wherein the coenzyme complex comprises one or more cofactor selected from the group consisting of coenzyme Q10, NADH, NADPH, coenzyme R and B-complex vitamins.

7. The composition of claim 6 , wherein the B-complex vitamins are selected from the group consisting of Vitamin B1, Vitamin B2, Vitamin B3, Vitamin B5, Vitamin B6, Vitamin B9, Vitamin B12, and combinations thereof.

8. The composition of claim 1 , further comprising D-ribose, L-arginine, L-carnitine or combinations thereof.

9. The composition of claim 1 , wherein the Lactic acid bacteria is selected from the group consisting of L. acidophilus, L. amylovorus, L. animalis, L. bavaricus, L. brevis, L. bulgaricus, L. casei spp casei, L. casei spp rhamnosus, L. crispatus, L. delbrueckii ssp lactis, L. eichmanni, L. fermentum, L. helveticus, L. jensenii, L. kefir, L. paracasei, L. pentosus L. plantarum, L. reuteri, L. salivarius, L. sake, Leu. cremoris, Leu. lactis, B. adolescentis, B. animalis, B. bifidum, B. breve, B. infantis, B longum, B. thermophilum, Ped. acidilactici, Ped. pentosus, Pep. assacharolyticus, Pep. productus, Pro. acidipropionici, Pro. freudenreichii, Pro. jensenii, Pro. theonii, S. cremoris, S. faecium, S. lactis, S. raffinolactis , and S. thermophiles.

10. The composition of claim 9 , wherein the Lactic acid bacteria is in the form of a freeze-dried powder or an emulsion.

11. The composition of claim 1 , wherein the effective dosage of the probiotic in a mixed composition range between 10 2 to 10 12 colony forming units, preferably between 10 5 to 10 10 colony forming units per serving.

12. A food or beverage comprising the composition of claim 1 .

13. A formulation for detoxification support comprising:

an elemental complex comprising zinc;

a coenzyme complex comprising at least two selected from the group consisting of coenzyme Q10, coenzyme R, Vitamin B1, Vitamin B2, Vitamin B3, Vitamin B5, Vitamin B6, Vitamin B9, and Vitamin B12;

a trigger complex comprising a dietary fiber, zinc-lactoferrin and a bicarbonate buffer, wherein zinc-lactoferrin comprises zinc ion covalently linked to the LF, and wherein the concentration of LF in the composition is from 0.2 to 5% (wt/wt); and

at least two of the following ingredients: Lactobacillus spp., Bifidobacterium spp., L-theanine, cranberry extract, tumeric root extract, inulin and blond psyllium.

14. The formulation of claim 13 , further comprising at least one additional component selected from the group consisting of D-ribose, L-arginine, and L-carnitine.

15. The formulation of claim 13 , wherein the dietary fiber comprises maltodextrin, glucomannan, guar gum, locust bean gum, prickly pear cactus and combinations thereof.

16. The formulation of claim 13 , wherein the lactoferrin is lactoferrin-(TCR).

17. The formulation of claim 13 , wherein the Lactobacillus spp. is selected from the group consisting of L. amylovorus, L. animalis, L. bavaricus, L. brevis, L. bulgaricus, L. casei spp casei, L. casei spp rhamnosus, L. crispatus, L. delbrueckii ssp lactis, L. eichmanni, L. fermentum, L. helveticus, L. jensenii, L. kefir, L. paracasei, L. pentosus L. plantarum, L. reuteri, L. salivarius , and L. sake.

18. The formulation of claim 13 , wherein the Bifidobacterium spp. is selected from the group consisting of B. adolescentis, B. animalis, B. bifidum, B. breve, B. infantis, B longum , and B. thermophilum.

19. A method of providing detoxification support comprising administering the formulation of claim 13 to an individual in need thereof.

Assignments (2)
CHANGE OF ADDRESS Recorded Jun 9, 2015
From: NAIDU LP
To: NAIDU LP
Reel/Frame 035866/0705 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 1, 2013
From: NAIDU, A. SATYANARAYAN; NAIDU, A. G. TEZUS; NAIDU, A. G. SREUS
To: NAIDU LP
Reel/Frame 030723/0502 →
Continuity (4)
Division 13096398 · Apr 28, 2011
Continuation In Part 11442473 · May 26, 2006
Provisional Application 60686257 · May 31, 2005
Related Publication 20130295066A1 · Nov 7, 2013